Instil Bio
Irene Hendrickson began their work experience in July 2019 as a Laboratory Assistant at HEMATOGENIX LABORATORY SERVICES LIMITED. Irene then transitioned to the role of Flow Cytometry Scientist in January 2020 and held this position until October 2021. In October 2021, Irene joined Instil Bio as an Associate Analytical Development Scientist.
Irene Hendrickson completed their Bachelor of Science degree in Neuroscience at The University of Manchester from 2014 to 2017. Following this, they pursued a Master of Research degree in Reproductive Biology at the same institution from 2017 to 2018.
This person is not in any offices
Instil Bio
1 followers
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK.